Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representatives of the following Investors are scheduled to visit our Gurugram Facility i.e. 'Medanta - The Medicity' for in-person meetings, on Friday, 17th February, 2023: S. No. Name of the Investor 1. Wellington International Management 2. Taiyo Pacific Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Kindly take the above on record.
16-02-2023
Bigul

Global Health Ltd - 543654 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Audio Recording

 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the below link of Audio recording of Earnings Conference Call held on Tuesday, February 14, 2023 hosted by JM Financials, for the Quarter III & Nine Months ended December 31, 2022 Results of the Company. https://d3b6u46udi9ohd.cloudfront.net/wp-content/uploads/2023/02/14130020/Medanta-Earnings-Call-Audio-Recording-Q3-FY23.mp3 This is for your information and record.
14-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sir/Madam, Pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith, the copies of Newspaper clippings of the Unaudited Financial Results of the Company for the Quarter III and nine months ended December 31, 2022, published in Financial Express (English) and Jansatta (Hindi) on Tuesday, 14th February, 2023. This is for your information and record.
14-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Dear Sir, Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 (SEBI Listing Regulations) read with Regulation 41(2) of SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018, (SEBI ICDR Regulations), we are enclosing herewith the Monitoring Agency Report, towards utilization of proceeds of Initial Public Offer of the Company for the quarter ended December 31, 2022, issued by CRISIL Ratings Limited. You are requested to take the above information on your record
14-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of Investor Presentation for the Quarter III & Nine Months ended December 31, 2022 financial results of the Company. Kindly take the above on record.
13-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Dear Sir, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Press Releases on: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended December 31, 2022; and 2. The binding term sheet for a new hospital at Indore on Operation & Management basis. This is for the information.
13-02-2023
Bigul

Global Health Ltd - 543654 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)

 Dear Sir(s), We would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, February 13, 2023, has inter alia, approved: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended December 31, 2022 (Results); and 2. The binding term sheet for a new hospital at Indore on Operation & Management basis. The details as required under Regulation 30 are in Exhibit. The certified copies of Results along with Limited Review Reports from the Statutory Auditors M/s Walker Chandiok & Co LLP, Chartered Accountants thereon, are enclosed herewith pursuant to Regulation 33 of Listing Regulations.
13-02-2023
Bigul

Global Health Ltd - 543654 - Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)

 Dear Sir(s), We would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, February 13, 2023, has inter alia, approved: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended December 31, 2022 (Results); and 2. The binding term sheet for a new hospital at Indore on Operation & Management basis. The details as required under Regulation 30 are in Exhibit. The certified copies of Results along with Limited Review Reports from the Statutory Auditors M/s Walker Chandiok & Co LLP, Chartered Accountants thereon, are enclosed herewith pursuant to Regulation 33 of Listing Regulations.
13-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an Earnings Conference Call is scheduled on Tuesday, February 14, 2023 at 4:00 P.M. (IST) to be hosted by JM Financials, for Quarter III & Nine Months ended December 31, 2022 results of the Company.
11-02-2023
Bigul

Global Health Ltd - 543654 - Board Meeting Intimation for Inter Alia, To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022.

 Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022.
04-02-2023
Next Page
Close

Let's Open Free Demat Account